Screener
Altimmune ALT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Altimmune’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 1,429 | 2,957 |
| Total current assets | 334,676 | 278,192 |
| Property and equipment, net | 208 | 312 |
| Other assets | 746 | 1,425 |
| Total assets | $335,630 | $279,929 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,530 | $2,717 |
Item 1. Financial Statements
FAQ
- What is Altimmune's deferred tax assets and other non-current assets?
- Altimmune (ALT) reported deferred tax assets and other non-current assets of $746K in Q1 2026.
- How has Altimmune's deferred tax assets and other non-current assets changed year-over-year?
- Altimmune's deferred tax assets and other non-current assets decreased by 53.9% year-over-year, from $1.62M to $746K.
- What is the long-term trend for Altimmune's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Altimmune's deferred tax assets and other non-current assets has grown at a 7.8% compound annual growth rate (CAGR), from $977.24K to $1.43M.
Ask your AI about Altimmune's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude